Concert Looks To Phase III In Alopecia Areata, Ahead Of Pfizer’s JAK Inhibitor

 
• By Joseph Haas
  
Desperate Young Man Touching His Bald Patches - Image
Concert hopes to bring the first drug therapy for alopecia areata to market
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D